![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright : © 2008 McKenna et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The Macaque Gut Microbiome in Health, Lentiviral Infection, and Chronic Enterocolitis 1 Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America 2 Tulane National Primate Research Center, Tulane University Health Science Center, Covington, Louisiana, United States of America 3 Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, Colorado, United States of America 4 Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, Colorado, United States of America 5 Department of Computer Science, University of Colorado at Boulder, Boulder, Colorado, United States of America Frederick M Ausubel, Editor Harvard Medical School, United States of America * To whom correspondence should be addressed. E-mail: bushman/at/mail.med.upenn.edu Received April 30, 2007; Accepted December 19, 2007. This article has been cited by other articles in PMC.Abstract The vertebrate gut harbors a vast community of bacterial mutualists, the composition of which is modulated by the host immune system. Many gastrointestinal (GI) diseases are expected to be associated with disruptions of host-bacterial interactions, but relatively few comprehensive studies have been reported. We have used the rhesus macaque model to investigate forces shaping GI bacterial communities. We used DNA bar coding and pyrosequencing to characterize 141,000 sequences of 16S rRNA genes obtained from 100 uncultured GI bacterial samples, allowing quantitative analysis of community composition in health and disease. Microbial communities of macaques were distinct from those of mice and humans in both abundance and types of taxa present. The macaque communities differed among samples from intestinal mucosa, colonic contents, and stool, paralleling studies of humans. Communities also differed among animals, over time within individual animals, and between males and females. To investigate changes associated with disease, samples of colonic contents taken at necropsy were compared between healthy animals and animals with colitis and undergoing antibiotic therapy. Communities from diseased and healthy animals also differed significantly in composition. This work provides comprehensive data and improved methods for studying the role of commensal microbiota in macaque models of GI diseases and provides a model for the large-scale screening of the human gut microbiome. Author Summary Bacterial mutualists within the gastrointestinal tract aid digestion, promote development of the gut immune system, and provide competitive barriers to pathogen invasion. The host, in return, provides bacteria with safe housing and food during lean times. The composition of the gut microbiota is controlled in part by the host immune system. In a variety of disease states, immune function can be altered, and gut morbidity is often associated, leading to the hypothesis that alterations in the GI microbiota may contribute to disease. In this study, the gut microbiota was characterized in 100 samples from rhesus macaques using pyrosequencing, which allowed 141,000 sequences from 16S rRNA genes to be generated and analyzed. Healthy animals were compared to animals with gut disorders, induced, for example by advanced simian AIDS. Many factors contributed to changes in the microbiota, including the sex of the animal of origin. Animals with chronic colitis showed differences in composition of the GI microbiota compared to healthy animals, providing an association between altered microbiota and disease. Introduction The human intestine is home to some 100 trillion microorganisms of at least 400 species. The density of bacterial cells in the colon has been estimated at 1011 to 1012 per ml, which makes it one of the most densely populated microbial habitats known [1,2]. The number of unique genes in the microbial pool is estimated to outnumber the genes in the human nuclear genome by two orders of magnitude [1,2], and these genes contribute many essential metabolic functions to the host. The great majority of gut bacterial species have not been cultured outside the human host and are known only by fragments of their DNA sequences. A few pioneering reports have begun to survey the intestinal microbiota of humans and mice using DNA sequencing of uncultured communities [1,3,4] or using microarray-based methods [5,6]. It is widely expected that human disease states will be linked to characteristic transitions in the intestinal microbiota, and connections have been proposed between GI bacterial communities and obesity [7,8] and Crohn's disease [9,10], but studies in this area are just beginning. Here we report characterization of GI microbial communities in rhesus macaques and their alteration accompanying colitis associated with SIV infection or in animals with chronic enterocolitis. The mammalian GI tract is a major locus of immune tissues responsible for blocking invasion by pathogens, and more recently, these tissues have been implicated in normal homeostasis of the gut microbiota as well. For example, B-cells of the gut associated lymphoid tissues (GALT) synthesize IgA, which is secreted in large amounts into the lumen of the gut, and mice genetically incapable of normal IgA synthesis have abnormally large proportions of anaerobes in the small intestine [11,12]. Secreted antibacterial peptides have also been implicated in regulating the composition of the gut microbiota [13,14]. Effects of host genotype are also documented by the finding that genetically obese mice have detectably different gut microbiota compared to wild-type controls [8]. HIV infection causes rapid and massive destruction of GALT [15–20], and HIV infection is also frequently associated with gastrointestinal disorders, many of which are of unexplained etiology [21]. Destruction of GALT and gastrointestinal disorders are also a well-characterized consequence of simian immunodeficiency virus (SIV) infection in macaques [15,16,22–24]. A role for the GI microbiota in AIDS disease progression has recently been suggested–bacterial antigens are proposed to pass through the damaged GI mucosa and promote immune activation, which in turn promotes viral replication and disease progression [20]. Chronic enterocolitis is fairly common in rhesus macaques even in the absence of SIV infection or other known infectious or parasitic agents. Analysis of the clinical course and histopathology of idiopathic chronic enterocolitis shows many parallels with human inflammatory bowel disease (IBD), and indeed the macaque disease has been studied as a model for the human disorder [24–26]. Evidence of proinflammatory dysfunction of the IL6-JAK-STAT3-SOCS3 pathway has been reported [24]. A role for the gut microbiota in human IBD has long been suspected, and several studies have profiled uncultured GI bacteria from healthy and diseased patients (e. g. [9,27]). Such studies have not yet yielded a clear-cut picture of the relationship of GI microbiota to pathogenesis, though a reduction in microbial diversity has been proposed. Studies of the macaque disease have suggested that several GI microbes may be slightly more common in macaques with an IBD-like disease, but the macaque GI communities have not been comprehensively analyzed [20,25]. Here we characterize the macaque GI microbial communities and compare community composition in health and GI disease. To profile the bacterial taxa present, we purified bacterial DNA from samples of intestinal contents, amplified segments of the 16S rRNA gene, determined the sequences using massively parallel pyrosequencing, then used these data to identify and quantify the types of bacteria present [28]. The approach used here was based on extensive reconstruction studies [29], which showed that known clustering of microbial communities could be recaptured using 16S rRNA gene sequences of lengths generated by pyrosequencing using technology commercialized by 454 Life Sciences [30]. These preliminary bioinformatic studies also disclosed that some short segments of the 16S rRNA gene sequence were especially useful for phylogenetic reconstruction, allowing optimized primers to be chosen for the study reported here. We found that the macaque microbiota was distinct from other vertebrates studied previously. Even in healthy animals the taxa present in the gut microbiota differed between individuals and changed substantially within individuals over time. Unexpectedly, communities from males and females also differed. Distinctive GI microbial communities were also obtained in samples of colonic contents taken at necropsy from animals with GI disease. Most of these animals were also treated with antibiotics to ameliorate their symptoms, so our analysis models human cases of colitis accompanied by antibiotic therapy. These data indicate that colitis and its treatment are associated with transitions in GI microbiota in the macaque, providing a model that may be useful in understanding the human GI microbiota in health and disease. Results Monitoring Macaque Intestinal Microbiota We surveyed a range of sample types and disease states for possible effects on the macaque GI microbiota. We analyzed a total of 100 samples, including healthy animals, SIV infected animals, and animals with chronic enterocolitis. For the colitic samples, some of the animals were SIV infected and had colitis as a result of simian AIDS, while others were colitic but not SIV infected. Sample types included colonic contents collected at necropsy, bacterial communities adhered to biopsy specimens from the upper and lower GI mucosa (jejunum and colon respectively), and stool (Table 1; detailed data for each animal is in Table S1).
DNA was isolated from all 100 samples and amplified by PCR using primers BSR357-A and BSF8-B, which anneal to conserved regions of bacterial 16S rRNA gene. All sequence reads extended from the BSR357-A primer. The median read length was 264 nt (Figure 1
The primers for the 16S rRNA gene sequences were each marked with a unique DNA bar code by including distinctive 4 base sequences in the primers between the 16S rRNA gene complementary region and the binding sites for the pyrosequencing primers (Figure 1 One DNA sample was sequenced twice to assess reproducibility. To determine the bacterial taxa present, the 16S rRNA gene sequences were aligned using NAST and GREENGENES and then inserted into pre-established phylogenetic trees of full length 16S rRNA gene sequences [34,35] using ARB. Over all the sequences analyzed in this study, 99.94% sequences aligned with previously determined 16S rRNA gene sequences (80 total sequences failed to align). The bacterial taxa in each sample were then tabulated. Comparison of the two independent sequencing experiments showed excellent reproducibility of the phylogenetic assignments (Figure 1 Ninety-four near-full length macaque bacterial 16S rRNA gene sequences from two communities were also determined by conventional Sanger sequencing to provide a check on the pyrosequencing data (Figure 1 Microbial Diversity in the Macaque Intestinal Microbiota We first investigated the bacterial diversity present in our 16S rRNA gene sequence data. Sequence reads were aligned using NAST and compiled in OTUPicker. When sequences were condensed under conditions demanding 99% identity, about 20,000 different operational taxonomic units (OTUs; groups defined by pairwise sequence identity) were found (Figure 2
In an attempt to estimate the total number of OTUs in each data set, the Chao 1 estimator was used, which uses frequency of isolation information to estimate the number of unseen OTUs present in the original sample. For most of the samples, the rarefaction curves on the Chao 1 estimates did not reached a stable value, indicating that the true numbers of OTUs in the samples are larger even than the Chao 1 estimates (53–1185 OTUs per sample; 97% identity criteria). Overall the richness of the bacterial taxa in the macaque GI microbiota was very high. A comparison of the estimated diversity in all 100 samples was carried out by computing the Shannon Diversity Index from the OTU data for each sample (Figure 2 Comparison of the Macaque, Human, and Mouse GI Microbiota A comparison of the macaque GI microbiota to that of humans [4] and mice [8] is shown in Figure 3
To compare human and mouse samples to the macaque pyrosequencing data, sequence reads determined by the Sanger method from human and mouse were first truncated to match the length and position of the macaque 16S rRNA gene sequences. The UniFrac comparison showed strong clustering by species of origin. Similar separation by species was obtained when pyrosequencing data was used for both the rhesus and murine samples (unpublished data). For the human and macaque samples, the communities clustered by species of origin even though samples from diverse anatomical sites were included for each species. The taxonomic groups from GI communities of each species were then compared. The bacterial taxa detected are summarized in Figure 4
The predominance of the phyla Firmicutes and Bacteroidetes were similar in all three vertebrates, and several lower-abundance phyla also overlapped. For example, Proteobacteria and Actinobacteria were found in both macaques and humans. Verrucomicrobia were detected in humans but were rare macaques. A distinctive feature of the macaques was the density of Phyla Spirochaetes, particularly members of the genus Treponema, which were present in abundance in macaques (Figure 4 In humans, within the Class Bacteroidetes, members of the genus Bacteroides have been reported to be a major and functionally significant component of the human intestinal microbiota [4,44,45], but of the 94 near full length 16S rRNA gene macaque sequences, only one was genus Bacteroides. More common were genus Prevotella (16/94 sequences), which is also common in humans, and Rikenella (18/94 sequences), which is rare or absent in humans [4]. These proportions of Bacteroidaceae and Prevotellaceae were similar in the shorter pyrosequencing reads. In macaques, comparison of microbial communities among animals showed considerable variation among individuals, both in the relative abundance of the major taxonomic groups and in the presence of minor groups (Figure 4 Distinctive Microbial Communities Associated with Different Anatomical Sites Figure 5
The samples from the upper GI mucosa formed a distinct cluster to the upper right of the diagram, indicating unique composition. Analysis of the taxa present indicates that the upper GI communities were depleted in bacteria from the Bacteroidetes and Clostridia classes compared to lower GI, colonic contents, or stool, and enriched in Baccili, Molicutes, and Gamma and EpsilonProteobacteria. Several minor groups were particularly common in upper GI samples, including Mycoplasmatales and Streptococaceae. Analyses of biopsies (with adherent bacteria) from the lower GI (ascending colon) showed that they intermingle with samples of colonic contents taken at necropsy, though a distinctive feature was the abundance of Helicobater at this site. Enterobacteriaceae were far more common in the upper and lower GI samples than in stool or colonic contents, indicative of probable adherence to mucosal surfaces. Stool samples form a cluster continuous with colonic contents but extending to the upper left of the UniFrac plot. Stool samples commonly differed from colonic contents samples by having greater representation of Spirochaetes and several minor groups. Distinctive Microbial Communities Associated with Sex of the Animal of Origin In an effort to identify additional parameters affecting the macaque GI microbiota, we asked whether communities clustered detectably in UniFrac analysis when partitioned by a variety of biological parameters. The parameters tested included sex of the animal of origin, age, disease state, antibiotic use, and viral infection. GI communities were analyzed as pools across all sample types, as pools of related samples (colonic contents plus stool), or as single sample types (stool only or colonic contents only). Unweighted UniFrac was used for these comparisons, which is based on the presence or absence of different taxa without regard to abundance. In samples of colonic contents taken at necropsy, or in samples of stool, a difference was seen between males and females. Separate clustering is illustrated for a pool of the two sample types in Figure 6
Altered Bacterial Taxa in Animals with Colitis The effects of disease states were then examined. Microbial communities from colonic contents were divided by whether host animals were diagnosed with colitis at necropsy (Table 1) and analyzed in unweighted UniFrac (Figure 7
The communities separated along the first principal coordinate by whether the animals were diagnosed with colitis (p < 0.05; t-test with label permutation), indicating that the disease and associated treatment resulted in a change in composition of the GI microbiota. An analysis of the relative diversity, as reported by the Shannon Index, revealed that diversity was consistently lower in the communities from colitic animals (Figure 7 Most of the animals with colitis had a history of multiple bouts of diarrhea requiring medical attention including fluid therapy and in many animals treatment with antibiotics (Table S1). The antibiotics chosen for therapy differed among the animals and included tetracycline, enrofloxacin, cefazolin, and tylosin. The time of treatment relative to euthanasia and the duration of treatment also varied. Only two animals were on antibiotics (tetracycline) at the time of euthanasia. Within the cluster of communities from animals with colitis (Figure 7 An analysis of the bacterial taxa that differed between the two groups revealed the family Campylobacteraceae (Epsilon-Proteobacteria) was much more common in animals with colitis–for the major Campylobacter OTU (97% criteria), five out of ten monkeys with colitis had this OTU, but none of the seven healthy monkeys had this OTU (G = 6.03, df = 1, p = 0.015). Two monkeys of unknown clinical status were also positive. A variety of additional taxa within the Bacteroidetes and Firmicutes phyla also changed in abundance significantly in assocation with colitis. The Campylobacter genus contains known enteric pathogens of humans ([47] and references therein), consistent with the idea that the presence of these groups was associated with pathogenesis in macaques. Of the animals detected as Campylobacter positive by sequence analysis, only two animals had positive cultures for Campylobacter when analyzed by conventional clinical methods. One explanation for the enrichment of Campylobacter would be that antibiotic treatment created an environment favorable for colonization, as has been suggested for Clostridia difficile in humans. Of the animals with colitis that were positive for Campylobacter, four had histories of recent antibiotic use but three did not, and for the four treated animals three different antibiotics were used (Table S1). Thus the presence of Campylobacter was not strongly associated with antibiotic treatment, consistent with the idea that Campylobacter was associated with colitis and not antibiotic use. SIV-infected animals were present in both the colitis and normal groups, and no strong clustering of the bacterial communities was associated with SIV infection when SIV infection was analyzed in isolation (data not shown). These data suggest that the alterations in community composition in SIV-infected animals with colitis was attributable to the colitis resulting from viral infection, and not the viral infection itself. Discussion In this study, we describe the composition of 100 uncultured GI microbial communities from healthy rhesus macaques and macaques with chronic colitis. Each community was characterized by an average of ~1,400 reads of 16S rRNA gene of median 264 nt in length. This work provides a detailed picture of the structure of the macaque GI microbiota, its dynamics, and changes associated with colitis with or without SIV infection. Macaque models are used in studying myriad GI diseases, including SIV-induced enteropathy, bacterial enteropathy, and inflammatory bowel disease. The data presented here provides detailed background, hypotheses and methods for assessing possible involvement of the full GI microbiota, and provides a model for investigating changes in the human GI microbiota in healthy and diseased individuals. The pyrosequencing method [30] allows large numbers of 16S rRNA gene sequence reads to be obtained while controlling the costs of data acquisition, greatly increasing the number of bacterial communities and species accessible to analysis compared to culture-based methods. In the bioinformatic approach used here, the pyrosequencing reads were analyzed after first inserting them into pre-existing phylogenetic trees formed from full-length 16S rRNA gene sequences, allowing relatively accurate phylogenetic placement despite the short sequences lengths [29]. Aligning pyrosequencing reads to a pre-existing tree also serves to minimize the effects of pyrosequencing errors, since single nucleotide substitutions that cause a sequence read to align with an incorrect full length sequence will be rare. Communities characterized by 16S rRNA gene sequence reads were compared to each other using UniFrac [38,40], which evaluates the distance between pairs of samples after alignment on phylogenetic trees based on the unique branch length leading to members of each community. One advantage of this approach is that the collection of pair-wise distances between communities can be subject to PCoA, allowing communities to be clustered along orthogonal axes of maximal variance. In a successful study of this type, clustering on each axis can report the effects of different biological variables. Previous studies of the vertebrate GI microbiota have indicated that many factors influence microbial populations, including host genotype [8,48], geography [49], antibiotic use [50], and diet [51]. Using UniFrac and PCoA, in combination with case-controlled samples, it is potentially possible to extract the effects of these and other variables and analyze each independently. Our analysis showed that the macaque microbiota differed significantly from that of mouse or human. Even when communities from different anatomical sites were considered, or when samples from healthy hosts were mixed with diseased hosts, the effect of species of origin was still predominant. For all three vertebrates, the Firmicutes and Bacteroidetes comprised the most abundant phyla, but the composition of minor groups differed and the taxa within the Firmicutes and Bacteroidetes also differed. A distinctive feature of the macaque samples was the abundance of Spirochaetes from the Treponema lineage. These Treponema differ from the spiral-shaped Helicobacter reported previously [41], which were also detected here. Analysis of full-length 16S rRNA gene clones (Figure 1 The analysis of healthy animals emphasized the many factors affecting composition of GI communities in macaques. The number of types of bacteria involved is very large–when macaque 16S rRNA gene sequences are grouped into OTUs at 97% or greater similarity, a threshold that has been suggested to correspond roughly to the species level, about 5,000 OTUs were identified. Microbial communities of individual animals differed from one another, and all animals followed longitudinally showed changes in community composition over time. Similarly in humans, GI microbial communities have been reported to differ among individuals and at different anatomical sites [4]. The macaque GI communities also clustered by the sex of the host animal, paralleling a proposal for sexual dimorphism in the GI microbiota in mice [46]. Samples from colonic contents of animals euthanized due to advanced colitis showed distinctive communities compared to similar samples from healthy controls, linking alterations in the GI microbial communities and GI pathogenesis. Samples from animals with colitis, whether associated with SIV infection or not, were indistinguishable. This emphasized that colitis itself (and associated therapeutic interventions) and not the cause of colitis was most tightly linked with altered GI microbiota. The presence of Campylobacter was strongly associated with colitis. The major Campylobacter OTU (97% threshold) was present in five out of ten animals with colitis, but in zero out of seven free of colitis (p = 0.014). Cultureable C. jejuni or C. coli were obtained only from two animals, indicating that the Campylobacter species detected were either too rare to detect by culture, or did not grow under the culture conditions used. Most of the macaques euthanized due to GI-disease were treated with antibiotics at some point during disease progression. Thus these findings model human clinical cases where antibiotic therapy can be indicated in the treatment of colitis, but antibiotic treatment complicates analysis of effects of GI disease alone. For the samples of colonic contents taken at necropsy, there were indications of clustering due to type of antibiotic used for treatment within the larger cluster of samples from animals with colitis, though the number of samples in each antibiotic group was too low for detailed analysis by antibiotic type. Our data are consistent with the idea that the disease state caused a shift in bacterial communities that was further shaped by the antibiotics used for treatment. The sequence-based approach described here has the potential to identify candidate pathogens involved in previously obscure disease conditions. Animal FH09 (Table S1) provides a case study. This animal suffered from prolonged chronic diarhhea of unknown cause. Exhaustive searches for a microbial pathogen by conventional culturing methods were negative. For unexplained reasons, placing the animal on a gluten-free diet helped ameliorate the condition, but eventually the animal declined and was euthanized for humanitarian reasons. Analysis of colonic contents taken at necropsy revealed a substantial number of 16S rRNA gene sequences (51 reads) that clustered with a group containing Campylobacter fetus and Campylobacter hyointestinalis. Evidently Campylobacters of this group are not detected in the usual culture assays. C. fetus has been implicated as an emerging pathogen and could well have been involved in the GI disease of FH09. These findings suggest that further analysis of the relationship between diet and C. fetus pathogenesis might be useful, and illustrate how the methods described here could be applied in diagnosis of human GI diseases of unknown etiology. In summary, this study presents the first use of DNA bar coding and pyrosequencing to analyze uncultured bacterial communities from the primate gut, and provides the deepest view into the gut microbiome from the largest sample of any non-human species to date. Using the macaque model and the methods reported here, it will be possible to investigate how the interaction among bacterial community members, together with alterations in the GI environment, leads to outgrowth of pathogenic forms and resultant disease. This study also paves the way for broader application of pyrosequencing to characterize the human microbiota in health and disease, which could potentially allow large-scale characterization of thousands of human samples with orders of magnitude less expense and effort than traditional Sanger sequencing. We will thus soon be able to identify those features of the microbiota (if any) that are common to all healthy individuals, and to assess the extent to which changes in the microbiota in animal models can help guide the development of therapy for human diseases. Materials and Methods Sample collection. Rhesus macaques (Macaca mulatta) were housed singly at the Tulane National Primate Research Center. For longitudinal studies of stool samples, four animals (CC47, FH40, CT64, DD05; here M1-M4) were infected intravenously with 100 TCID50 SIVmac251 on study day 0. Fecal samples were collected prior to infection (t1), at day 7 (t3), day 14 (t4), day 28 (t6) and day 56 (t10) post infection. These are standard time points for examination of early events in the pathogenesis of AIDS and are associated with peak viremia (day 14) and establishment of viral set point (by day 56). Stool samples for control animals (AM87, DG23, CC79, BA02; here C1-C4) were collected similarly over an eight week period. For samples of colonic contents, each was collected from the ascending colon at necropsy within one hour of euthanasia with an intravenous overdose of phenobarbital. All samples were immediately frozen to −80 °C. Samples were shipped on dry ice and stored at −80 °C until processing. In addition, intestinal biopsies of the upper (jejunum) and lower (ascending colon) were obtained by standard techniques. These biopsies were immediately frozen as for colonic contents. Housing and handling of animals were in accordance with the Guide for the Care and Use of Laboratory Animals (U.S. Public Health Service) and the Animal Welfare Act. All protocols and procedures were reviewed and approved by the Tulane University Institutional Animal Care and Use Committee. Additional animals studied, their clinical conditions, and detailed ecological descriptions of samples are in Table S1. Extraction and purification of DNA. Total DNA was extracted from frozen stool using the QIAamp® DNA Stool Mini Kit (Qiagen, Inc., Valencia CA), following the manufacturer's protocol for pathogen detection. PCR amplification of bacterial 16S rRNA gene sequences. For samples from each animal and at each time-point, the 16S rRNA gene was amplified from extracted DNA using the composite forward primer 5′-GCCTCCCTCGCGCCATCAGNNNNCTGCTGCCTYCCGTA-3′ where the underlined sequence is that of 454 Life Sciences® primer A and in italics is the broad range bacterial primer BSR357. The reverse primer was 5′-GCCTTGCCAGCCCGCTCAGNNNN AGAGTTTGATCCTGGCTCAG-′3, where the underlined sequence is that of 454 Life Sciences® primer B and in italics is the broad range bacterial primer BSF8. The NNNN designates the unique four base bar code used to tag each PCR product. Reaction conditions were as follows: 5.0 μl 10× PCR buffer II (Applied Biosystems, Foster City, CA), 3.0 μl MgCl2 (25 mM; Applied Biosystems), 2.5 μl Triton X-100 (1%), 2.0 μl deoxyribonucleoside triphosphates (10 mM), 1.0 μl forward primer and 1.0 μl reverse primer (20 pmol/μl each) and 0.5 μl AmpliTaq® DNA polymerase (5U/μl; Applied Biosystems) and 100 ng of template DNA in a total reaction volume of 50 μl. Reactions were run in a GeneAmp® PCR System 9700 cycler (Applied Biosystems) using the following cycling parameters: 5 minutes denaturing at 95 °C followed by 20 cycles of 30 secs at 95 °C (denaturing), 30 secs at 56 °C (annealing) and 90 secs at 72 °C (elongation), with a final extension at 72 °C for 7 minutes. Four independent PCR reactions were performed for each sample along with a no template negative control. Gel purification and pyrosequencing. Each PCR product was gel purified from a 0.8% agarose gel. DNA was isolated using the QIAquick® Gel extraction kit (Qiagen, Inc., Valencia CA). 100 ng of each of the 100 gel purified DNAs was added to a master pool of DNA which was sent for pyrosequencing with primer A as described [30,54]. Several studies have analyzed sources of error in 454 sequencing runs, which informed our choices for quality control here [37,54,55]. For a sequence to pass quality control, it needed to (1) show a perfect match to the bar code and 16S rRNA gene primer, (2) be at least 50 nt in length, (3) have no more than two undetermined bases in the sequence read, and (4) find at least a 75% match to a previously determined 16S rRNA gene sequence after alignment with NAST (http://greengenes.lbl.gov/). The sequences were inserted into the 16S rRNA gene tree constructed by Hugenholz et al. [56] using the parsimony insertion tool from ARB software (http://www.arb-home.de/). A “termini” filter was used for the parsimony insertion. After applying this criteria, 36,652,141 bases of sequence were available for analysis. All sequence data will be deposited at NCBI upon acceptance of this manuscript for publication. Bioinformatic analysis. OTU clustering and analysis was carried out using OTUPicker (M. Hamady and R. Knight, unpublished). Clustering and principal coordinate analysis were conducted using UniFrac [29,38,39]. UniFrac analysis can be carried out based on the presence and absence of bacterial taxa (unweighted UniFrac), or taking into account abundance information on each group (weighted UniFrac); Figures 3 Errors in pyrosequencing may occur at a rate of about 0.25% [37], suggesting that the most of the 260-nucleotide sequences that remain after filtering will contain either 0 or 1 errors. Single- nucleotide errors will not affect either of the analyses we present (high-level taxonomic breakdowns or UniFrac) substantially, as they are unlikely to cause assignment of pyrosequence reads to the wrong taxonomic group and contribute almost no branch length to the phylogenetic tree used for UniFrac analyses. However, these sequencing errors could affect estimates of the total number of OTUs at a given threshold, so some caution in interpreting the total number of species-level taxa in the samples is required. Using the Poisson model, we would expect only 4.4 × 10−5% of the reads to contain the seven errors that would be required to form a new species-level at the 97% OTU threshold. Thus, it is unlikely that a single OTU in the analysis was generated through that mechanism. Table S1: Characteristics of Samples of Uncultured Macaque GI Communities Used in This Study This table provides the description of monkeys sampled, clinical parameters for disease states, and ecological statistics describing the communities sampled. (93 KB XLS) Click here for additional data file.(94K, xls) Table S2: Near-full-length 16S rRNA Gene Sequences Determined by the Sanger Method, and Their Taxonomic Positions These sequences allow finer discrimination of the major macaque GI bacterial taxa. (404 KB XLS) Click here for additional data file.(404K, xls) Acknowledgments We thank the Keck Foundation for a pilot grant to RK and FDB. We thank Paul Sniegowski, Dustin Britton, and Jeff Weiser for helpful discussions; Dan Frank for critical reading of the manuscript; and Steven Holland for creating a command-line version of DOTUR. Footnotes Author contributions. PM, CH, NM, PPA, AL, ZL, CAL, MH, RK, and FDB contributed to the design of experiments and interpretation of data. Animal work was carried out at the Tulane National Primate Research Center by PPA and AL. Sequencing was carried out by PM, CH, NM, and FDB. Data analysis was carried out by PM, CH, AL, ZL, CAL, MH, RK, and FDB. Funding. This work was supported in part by Public Health Service Grants RR00164, RR016930, and AI045008; NIH grants P01DK078669, T32GM065103, and GM08759; grants from the University of Pennsylvania Center for AIDS Research and the Colorado Center for AIDS Research; and by the Keck RNA Bioinformatics Initiative at the University of Colorado, Boulder. Competing interests. The authors have declared that no competing interests exist. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Cell. 2006 Feb 24; 124(4):837-48.
[Cell. 2006]Proc Natl Acad Sci U S A. 1998 Jun 9; 95(12):6578-83.
[Proc Natl Acad Sci U S A. 1998]Science. 2006 Jun 2; 312(5778):1355-9.
[Science. 2006]Science. 2005 Jun 10; 308(5728):1635-8.
[Science. 2005]Nucleic Acids Res. 2006 Jan 10; 34(1):e5.
[Nucleic Acids Res. 2006]Science. 2002 Nov 15; 298(5597):1424-7.
[Science. 2002]Proc Natl Acad Sci U S A. 2004 Feb 17; 101(7):1981-6.
[Proc Natl Acad Sci U S A. 2004]Nat Immunol. 2000 Aug; 1(2):113-8.
[Nat Immunol. 2000]Nat Immunol. 2003 Mar; 4(3):269-73.
[Nat Immunol. 2003]Proc Natl Acad Sci U S A. 2005 Aug 2; 102(31):11070-5.
[Proc Natl Acad Sci U S A. 2005]Nature. 2005 Apr 28; 434(7037):1148-52.
[Nature. 2005]Nat Med. 2006 Dec; 12(12):1365-71.
[Nat Med. 2006]Am J Gastroenterol. 2000 Dec; 95(12):3482-9.
[Am J Gastroenterol. 2000]Science. 1998 Apr 17; 280(5362):427-31.
[Science. 1998]J Infect Dis. 1994 May; 169(5):1116-20.
[J Infect Dis. 1994]Am J Pathol. 2007 Dec; 171(6):1952-65.
[Am J Pathol. 2007]Clin Diagn Lab Immunol. 2005 Jan; 12(1):192-7.
[Clin Diagn Lab Immunol. 2005]J Clin Microbiol. 2006 Nov; 44(11):3980-8.
[J Clin Microbiol. 2006]J Pathol. 2006 Aug; 209(4):532-9.
[J Pathol. 2006]Nat Med. 2006 Dec; 12(12):1365-71.
[Nat Med. 2006]Cell. 1986 May 9; 45(3):325-6.
[Cell. 1986]Nucleic Acids Res. 2007; 35(18):e120.
[Nucleic Acids Res. 2007]Nature. 2005 Sep 15; 437(7057):376-80.
[Nature. 2005]Appl Environ Microbiol. 2006 Mar; 72(3):2110-7.
[Appl Environ Microbiol. 2006]Microbiology. 2002 Nov; 148(Pt 11):3651-60.
[Microbiology. 2002]Nature. 2005 Sep 15; 437(7057):376-80.
[Nature. 2005]Nucleic Acids Res. 2004; 32(4):1363-71.
[Nucleic Acids Res. 2004]Nucleic Acids Res. 2006 Jul 1; 34(Web Server issue):W394-9.
[Nucleic Acids Res. 2006]Genome Biol. 2007; 8(7):R143.
[Genome Biol. 2007]Science. 2005 Jun 10; 308(5728):1635-8.
[Science. 2005]Proc Natl Acad Sci U S A. 2005 Aug 2; 102(31):11070-5.
[Proc Natl Acad Sci U S A. 2005]BMC Bioinformatics. 2006 Aug 7; 7():371.
[BMC Bioinformatics. 2006]Appl Environ Microbiol. 2005 Dec; 71(12):8228-35.
[Appl Environ Microbiol. 2005]Anaerobe. 2003 Feb; 9(1):45-55.
[Anaerobe. 2003]Clin Infect Dis. 1997 Sep; 25 Suppl 2():S186-8.
[Clin Infect Dis. 1997]J Clin Microbiol. 2003 Mar; 41(3):1187-91.
[J Clin Microbiol. 2003]Science. 2005 Jun 10; 308(5728):1635-8.
[Science. 2005]Science. 2003 Mar 28; 299(5615):2074-6.
[Science. 2003]Appl Environ Microbiol. 2006 Oct; 72(10):6773-9.
[Appl Environ Microbiol. 2006]Nature. 2000 Feb 10; 403(6770):665-8.
[Nature. 2000]Nature. 2005 Sep 15; 437(7057):376-80.
[Nature. 2005]Nucleic Acids Res. 2007; 35(18):e120.
[Nucleic Acids Res. 2007]BMC Bioinformatics. 2006 Aug 7; 7():371.
[BMC Bioinformatics. 2006]Appl Environ Microbiol. 2005 Dec; 71(12):8228-35.
[Appl Environ Microbiol. 2005]Proc Natl Acad Sci U S A. 2005 Aug 2; 102(31):11070-5.
[Proc Natl Acad Sci U S A. 2005]Appl Environ Microbiol. 2005 Jul; 71(7):4153-5.
[Appl Environ Microbiol. 2005]J Clin Microbiol. 2004 Mar; 42(3):1203-6.
[J Clin Microbiol. 2004]Anaerobe. 2003 Feb; 9(1):45-55.
[Anaerobe. 2003]J Appl Microbiol. 2006 Oct; 101(4):948-55.
[J Appl Microbiol. 2006]Appl Environ Microbiol. 1985 Aug; 50(2):212-9.
[Appl Environ Microbiol. 1985]Science. 2005 Jun 10; 308(5728):1635-8.
[Science. 2005]Appl Environ Microbiol. 2006 Oct; 72(10):6773-9.
[Appl Environ Microbiol. 2006]Nature. 2005 Sep 15; 437(7057):376-80.
[Nature. 2005]Proc Natl Acad Sci U S A. 2006 Aug 8; 103(32):12115-20.
[Proc Natl Acad Sci U S A. 2006]Genome Biol. 2007; 8(7):R143.
[Genome Biol. 2007]Nucleic Acids Res. 2007; 35(13):e91.
[Nucleic Acids Res. 2007]Genome Biol. 2002; 3(2):REVIEWS0003.
[Genome Biol. 2002]Nucleic Acids Res. 2007; 35(18):e120.
[Nucleic Acids Res. 2007]BMC Bioinformatics. 2006 Aug 7; 7():371.
[BMC Bioinformatics. 2006]Appl Environ Microbiol. 2007 Mar; 73(5):1576-85.
[Appl Environ Microbiol. 2007]Genome Biol. 2007; 8(7):R143.
[Genome Biol. 2007]